Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 01, 2022	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000834237-22-004576.pdf
Jan 10, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-002403.pdf 0001104659-22-002403.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000005.pdf 0001708138-22-000005.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000006.pdf 0001708138-22-000006.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000007.pdf 0001708138-22-000007.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000008.pdf 0001708138-22-000008.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000006.pdf 0001883850-22-000006.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000008.pdf 0001883850-22-000008.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000007.pdf 0001883850-22-000007.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000009.pdf 0001883850-22-000009.xls

Data provided by Kaleidoscope.

Investors & Media